Results 21 to 30 of about 19,810 (202)

Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy [PDF]

, 2023
We found that urine tenofovir (TFV) levels >1500 ng/mL strongly predict virologic suppression among people with human immunodeficiency virus taking tenofovir alafenamide (odds ratio, 5.66; 95% confidence interval, 1.59-20.14; P = .007).
Imbert, Elizabeth, Watabe, Joseph, Okochi, Hideaki, Arreguin, Mireya, Spinelli, Matthew, Chattopadhyay, Anindita, Gandhi, Monica, Johnson, Kelly A, Glidden, David V, Hickey, Matthew D   +9 more
core   +1 more source

Acquired Fanconi Syndrome from Tenofovir Treatment in a Patient with Hepatitis B

Case Reports in Hepatology, 2023
Fanconi syndrome is a rare disease of generalized proximal tubule dysfunction which can be acquired secondary to certain medications, including tenofovir, a commonly used hepatitis B treatment.
Shirley X. Jiang, John Duncan, Hin Hin Ko   +2 more
doaj   +1 more source

A possible case of bictegravir-associated severe unconjugated hyperbilirubinemia

AIDS Research and Therapy, 2023
Background Bictegravir (BIC) co-formulated with emtricitabine (FTC) and tenofovir alafenamide (TAF) is approved by Federal Food and Drug Administration in 2018 for both treatment-naïve and experienced persons living with HIV (PLWH).
Kanak Parmar, Poemlarp Mekraksakit, Kenneth Nugent, Jacob Nichols   +3 more
doaj   +1 more source

Baseline characteristics of 539 patients on Emtricitabine/Tenofovir Alafenamide/Bictegravir, enrolled in the SCOLTA cohort.

, 2023
Baseline characteristics of 539 patients on Emtricitabine/Tenofovir Alafenamide/Bictegravir, enrolled in the SCOLTA cohort.
Paolo Bonfanti (383173), Eleonora Sarchi (622896), Antonio Di Biagio (316138), Goffredo Angioni (9729449), Giuseppe Vittorio De Socio (7513244), Giovanni Cenderello (648635), Paolo Maggi (4162249), Stefania Piconi (7513250), Benedetto Maurizio Celesia (7513253), Letizia Attala (16806786), Olivia Bargiacchi (16806789), Barbara Menzaghi (316146), Nicola Squillace (691608), Alessandra Bandera (340441), Lucia Taramasso (344095), Katia Falasca (4162252), Laura Valsecchi (13852802), Filomena Simeone (16806783), Elena Ricci (316160), Giancarlo Orofino (485009), Giovanni Francesco Pellicanò (4162270), Antonio Cascio (378202)   +21 more
core   +1 more source

Switching to tenofovir alafenamide in hbv: nationwide real life data of efficacy and safety from Turkey [PDF]

, 2021
Tenofovir alafenamide (TAF) is a new prodrug of tenofovir used for the treatment of HIV-1 and HBV infections. It provides more efficient intracellular tenofovir concentrations at a relatively lower dose than provided by tenofovir disoproxil fumarate (TDF)
Tabak, Fehmi, Görenek, Levent, Güner, Rahmet, Erdem, Hazal, Sume, Serkan, Sırmatel, Fatma, İnce, Nevin, Şener, Alper, Koç, Meliha Merih, Karabay, Oğuz, Çeken, Sabahat, Türker, Kamuran, Batırel, Ayşe, Günal, Özgür, Yörük, Gülşen, Köksal, İftihar, Bozkurt, İlkay, Yıldız, Dilek, Köse, Şükran, Yıldız, İlknur Esen, İnan, Dilara, Yamazhan, Tansu   +21 more
core   +1 more source

RP-HPLC method development and validation for the estimation of Emtricitabine, Bictegravir and Tenofovir alafenamide in bulk and pharmaceutical dosage form

Journal of Taibah University for Science, 2019
A new simple, accurate, precise RP-HPLC [reverse phase high performance liquid chromatography] method was developed for the simultaneous estimation of the Emtricitabine, Bictegravir and Tenofovir alafenamide in pharmaceutical dosage form.
Tej Kumar Kokkirala, Duvvuri Suryakala
doaj   +1 more source

Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV

Viruses, 2023
Tenofovir has been hypothesized to be effective against COVID-19 and is available as two prodrugs, tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF), both part of antiretroviral therapy (ART) regimens.
María F. Rombini, Diego Cecchini, Sofía Diana Menendez, Liliana Calanni, Rosana Cuini, Elena Obieta, María M. Greco, Fabricio Morales, Laura Morganti, Claudia Migazzi, Yasmin El Kozah, Pablo Parenti, Isabel Cassetti, on behalf of the COVIDARE Study Team   +13 more
doaj   +1 more source

Real-life experience of tenofovir alafenamide fumarate: The pythagorean cohort

, 2021
Real-life experience of tenofovir alafenamide fumarate: The pythagorean ...
Kalkan, İrem Akdemir, Aktar, Fesih, Mete, Ayse Özlem, Dal, Tuba, Harputoğlu, Murat, Çelen, Mustafa Kemal, Toplu, Sibel Altunışık, Demir, Yakup, Karaşahin, Ömer   +8 more
core   +1 more source

Real-life Data for Tenofovir Alafenamide Fumarate Treatment of Hepatitis B: the Pythagoras Cohort

, 2021
Background: Chronic hepatitis B (CHB) is a viral infection that can result in life-threatening conditions, such as hepatocellular carcinoma and cirrhosis.
Sarigul, Figen, Kandemir, Ozlem, Akgul, Fethiye, TAŞOVA, YEŞİM, Karasahin, Omer, BAYINDIR, YAŞAR, Esmer, Fatih, NAZİK, SELÇUK, Yildiz, Yesim, İNAN, DİLARA, Oren, Meryem Merve, Ayhan, Merve, Celen, Mustafa K., ALTUNIŞIK TOPLU, SİBEL, Kaya, Safak, Kalkan, Irem Akdemir, Dal, Tuba, Akar, Fesih, AKDEMİR KALKAN, İREM, KÖMÜR, SÜHEYLA, Tunc, Nurettin, Mete, Ayse Ozlem, BALIN, ŞAFAK ÖZER, Harputoglu, Murat, ÇELEN, MUSTAFA KEMAL, Demir, Yakup, Aktar, Fesih, Balın, Safak Ozer, Bayındır, Yaşar, Yıldız, Yeşim, Toplu, Sibel Altunisik, Toplu, Sibel Altunışık   +31 more
core   +1 more source

Process for the preparation of Tenofovir Alafenamide Monofumarate [PDF]

, 2022
The present disclosure provides an improved process for the preparation of Tenofovir alafenamide monofumarate with reproducibly in good purity and ...
, MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan; Sajja Eswaraiah; Rajeshwar Reddy Sagyam; Parameshwarappa Gangajji; Praveen Velishala
core